EMA Advises Caution on Mounjaro's Impact on Oral Contraceptive Effectiveness

The European Medicines Agency's CHMP has issued a warning regarding Mounjaro (tirzepatide) and its potential to reduce the reliability of oral contraceptives. Healthcare professionals are now advised to recommend additional contraception for women of childbearing potential using Mounjaro, as limited data exists on its interaction with oral contraceptives in various patient groups. This is important for patient safety and effective family planning.